The global hemapheresis market is projected to showcase considerable growth during the forecast period. Hemapheresis is a medical procedure that involves removing whole blood from a donor’s body for separating and analyzing the individual components of the blood so that the desired blood component can be removed. This procedure is used for the collection of the blood components namely, plasma and platelets.The growth of the market is attributed to the increasing prevalence of chronic diseases that includes CHDs (Coronary Heart Diseases), CVDs (Cardiovascular Diseases), Cancer, neurological disorders, blood disorders among others. In addition, the growing demand for plasma in pharmaceutical and biotechnology companies is further expected to boost the growth of the global hemapheresis market.



Get Free Sample Copy @

https://www.omrglobal.com/request-sample/hemapheresis-market



There has been a significant increase in the number of patients with various blood-related diseases, neurological disorders and metabolic diseases across the globe. The blood cells, lymph nodes, and bone marrow are affected by various cancers including leukemia, and myelodysplastic syndromes (MDS). Hemapheresis has been widely adopted technology for reducing the number of white cells until other medications can control them. As per the Leukemia & Lymphoma Society (LLS) in 2018, approximately every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 1.3 million people in the US are either living with or are in remission from, leukemia, lymphoma or myeloma. With the rise in such disease, hemapheresistechnology has been widely adopted for the treatment of these diseases.



Browse for Full Report at:

https://www.omrglobal.com/industry-reports/hemapheresis-market


North America is projected to hold a considerable market share owing to the rising prevalence of chronic diseases in the region. According to WHO, the incidence and prevalence rate of heart attacks are highest in North America, which is responsible for 0.7 million fatalities each year. According to the Heart & Stroke Foundation in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease.According to the report of Epilepsy Canada, in 2018, 0.6% of Canadian populations were having epilepsy. According to the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer will be diagnosed in the US. The utility of hemapheresis to treat these diseases is expected to drive the growth of hemapheresis market in North America.



Current market trends covered in the market report

Increasing prevalence of chronic diseases across the globe.
Growing awareness related o blood safety across the globe.
Asia-Pacific to exhibit a significant growth rate in the global hemapheresis market.
Significant rise in the incidences of complex surgical procedures.


HemapheresisMarket Segmentation

By Technology
Centrifugation
Membrane Separation

By Product
Hemapheresis Devices
Hemapheresis Disposables

By Application
Hematology
Neurology
Renal Diseases
Others


Hemapheresis Market – Segment by Region

North America
The US
Canada

Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific
China
Japan
India
Rest of Asia-Pacific

Rest of the World
Latin America
Middle-East Africa


For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/hemapheresis-market



About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404